231 related articles for article (PubMed ID: 25027323)
1. Exploiting the interaction between Grp94 and aggregated myocilin to treat glaucoma.
Stothert AR; Suntharalingam A; Huard DJ; Fontaine SN; Crowley VM; Mishra S; Blagg BS; Lieberman RL; Dickey CA
Hum Mol Genet; 2014 Dec; 23(24):6470-80. PubMed ID: 25027323
[TBL] [Abstract][Full Text] [Related]
2. Glucose-regulated protein 94 triage of mutant myocilin through endoplasmic reticulum-associated degradation subverts a more efficient autophagic clearance mechanism.
Suntharalingam A; Abisambra JF; O'Leary JC; Koren J; Zhang B; Joe MK; Blair LJ; Hill SE; Jinwal UK; Cockman M; Duerfeldt AS; Tomarev S; Blagg BS; Lieberman RL; Dickey CA
J Biol Chem; 2012 Nov; 287(48):40661-9. PubMed ID: 23035116
[TBL] [Abstract][Full Text] [Related]
3. Different Grp94 components interact transiently with the myocilin olfactomedin domain in vitro to enhance or retard its amyloid aggregation.
Huard DJE; Jonke AP; Torres MP; Lieberman RL
Sci Rep; 2019 Sep; 9(1):12769. PubMed ID: 31484937
[TBL] [Abstract][Full Text] [Related]
4. Trifunctional High-Throughput Screen Identifies Promising Scaffold To Inhibit Grp94 and Treat Myocilin-Associated Glaucoma.
Huard DJE; Crowley VM; Du Y; Cordova RA; Sun Z; Tomlin MO; Dickey CA; Koren J; Blair L; Fu H; Blagg BSJ; Lieberman RL
ACS Chem Biol; 2018 Apr; 13(4):933-941. PubMed ID: 29402077
[TBL] [Abstract][Full Text] [Related]
5. Ligands for glaucoma-associated myocilin discovered by a generic binding assay.
Orwig SD; Chi PV; Du Y; Hill SE; Cavitt MA; Suntharalingam A; Turnage KC; Dickey CA; France S; Fu H; Lieberman RL
ACS Chem Biol; 2014 Feb; 9(2):517-25. PubMed ID: 24279319
[TBL] [Abstract][Full Text] [Related]
6. Functional analysis of the glaucoma-causing TIGR/myocilin protein: integrity of amino-terminal coiled-coil regions and olfactomedin homology domain is essential for extracellular adhesion and secretion.
Gobeil S; Letartre L; Raymond V
Exp Eye Res; 2006 Jun; 82(6):1017-29. PubMed ID: 16466712
[TBL] [Abstract][Full Text] [Related]
7. The glaucoma-associated olfactomedin domain of myocilin is a novel calcium binding protein.
Donegan RK; Hill SE; Turnage KC; Orwig SD; Lieberman RL
J Biol Chem; 2012 Dec; 287(52):43370-7. PubMed ID: 23129764
[TBL] [Abstract][Full Text] [Related]
8. The glaucoma-associated olfactomedin domain of myocilin forms polymorphic fibrils that are constrained by partial unfolding and peptide sequence.
Hill SE; Donegan RK; Lieberman RL
J Mol Biol; 2014 Feb; 426(4):921-35. PubMed ID: 24333014
[TBL] [Abstract][Full Text] [Related]
9. Progress toward development of a proteostasis drug for myocilin-associated glaucoma.
Huard DJ; Lieberman RL
Future Med Chem; 2018 Jun; 10(12):1391-1393. PubMed ID: 29788763
[No Abstract] [Full Text] [Related]
10. Histochemical Analysis of Glaucoma Caused by a Myocilin Mutation in a Human Donor Eye.
van der Heide CJ; Alward WLM; Flamme-Wiese M; Riker M; Syed NA; Anderson MG; Carter K; Kuehn MH; Stone EM; Mullins RF; Fingert JH
Ophthalmol Glaucoma; 2018; 1(2):132-138. PubMed ID: 30906929
[TBL] [Abstract][Full Text] [Related]
11. Aggregated myocilin induces russell bodies and causes apoptosis: implications for the pathogenesis of myocilin-caused primary open-angle glaucoma.
Yam GH; Gaplovska-Kysela K; Zuber C; Roth J
Am J Pathol; 2007 Jan; 170(1):100-9. PubMed ID: 17200186
[TBL] [Abstract][Full Text] [Related]
12. Rescue of glaucoma-causing mutant myocilin thermal stability by chemical chaperones.
Burns JN; Orwig SD; Harris JL; Watkins JD; Vollrath D; Lieberman RL
ACS Chem Biol; 2010 May; 5(5):477-87. PubMed ID: 20334347
[TBL] [Abstract][Full Text] [Related]
13. Intracellular sequestration of hetero-oligomers formed by wild-type and glaucoma-causing myocilin mutants.
Gobeil S; Rodrigue MA; Moisan S; Nguyen TD; Polansky JR; Morissette J; Raymond V
Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3560-7. PubMed ID: 15452063
[TBL] [Abstract][Full Text] [Related]
14. Myocilin misfolding and glaucoma: A 20-year update.
Saccuzzo EG; Youngblood HA; Lieberman RL
Prog Retin Eye Res; 2023 Jul; 95():101188. PubMed ID: 37217093
[TBL] [Abstract][Full Text] [Related]
15. Structural basis for misfolding in myocilin-associated glaucoma.
Donegan RK; Hill SE; Freeman DM; Nguyen E; Orwig SD; Turnage KC; Lieberman RL
Hum Mol Genet; 2015 Apr; 24(8):2111-24. PubMed ID: 25524706
[TBL] [Abstract][Full Text] [Related]
16. Targeting the ER-autophagy system in the trabecular meshwork to treat glaucoma.
Stothert AR; Fontaine SN; Sabbagh JJ; Dickey CA
Exp Eye Res; 2016 Mar; 144():38-45. PubMed ID: 26302411
[TBL] [Abstract][Full Text] [Related]
17. Binding of a glaucoma-associated myocilin variant to the αB-crystallin chaperone impedes protein clearance in trabecular meshwork cells.
Lynch JM; Li B; Katoli P; Xiang C; Leehy B; Rangaswamy N; Saenz-Vash V; Wang YK; Lei H; Nicholson TB; Meredith E; Rice DS; Prasanna G; Chen A
J Biol Chem; 2018 Dec; 293(52):20137-20156. PubMed ID: 30389787
[TBL] [Abstract][Full Text] [Related]
18. Keeping an eye on myocilin: a complex molecule associated with primary open-angle glaucoma susceptibility.
Menaa F; Braghini CA; Vasconcellos JP; Menaa B; Costa VP; Figueiredo ES; Melo MB
Molecules; 2011 Jun; 16(7):5402-21. PubMed ID: 21709622
[TBL] [Abstract][Full Text] [Related]
19. Glaucomatous MYOC mutations activate the IL-1/NF-κB inflammatory stress response and the glaucoma marker SELE in trabecular meshwork cells.
Itakura T; Peters DM; Fini ME
Mol Vis; 2015; 21():1071-84. PubMed ID: 26396484
[TBL] [Abstract][Full Text] [Related]
20. Elevated amounts of myocilin in the aqueous humor of transgenic mice cause significant changes in ocular gene expression.
Paper W; Kroeber M; Heersink S; Stephan DA; Fuchshofer R; Russell P; Tamm ER
Exp Eye Res; 2008 Sep; 87(3):257-67. PubMed ID: 18602390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
